Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Schiffman

Showing results (71-80 of 498) with videos related to

Pageof 50
Sort By:
American Journal of Clinical Pathology|February 6, 2007
The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assaysMark H Stoler, Philip E Castle, Diane Solomon, et al.
Obstetrics and Gynecology|June 2, 2007
Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significanceMahboobeh Safaeian, Diane Solomon, Sholom Wacholder, et al.
Journal of Lower Genital Tract Disease|April 4, 2020
An Introduction to the 2019 ASCCP Risk-Based Management Consensus GuidelinesMark Schiffman, Nicolas Wentzensen, Rebecca B Perkins, et al.
Preventive Medicine|May 19, 2024
Response letter to "Understanding the age-related epithelial shifts at the uterine cervix and the area of risk for squamous cell cervical cancer"Kanan T Desai, John Doorbar, Silvia de Sanjose, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 15, 2005
Evaluating the risk of cervical precancer with a combination of cytologic, virologic, and visual methodsSophia S Wang, Joan L Walker, Mark Schiffman, et al.
JAMA|August 8, 2023
Cervical Cancer Screening: A ReviewRebecca B Perkins, Nicolas Wentzensen, Richard S Guido, et al.
American Journal of Clinical Pathology|April 19, 2007
The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS reportPhilip E Castle, Mark H Stoler, Diane Solomon, et al.
Global Health, Science and Practice|July 1, 2018
Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening?Shannon L Silkensen, Mark Schiffman, Vikrant Sahasrabuddhe, et al.
Cancer|May 13, 2005
Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytologyMichelle J Khan, Edward E Partridge, Sophia S Wang, et al.
Journal of Lower Genital Tract Disease|December 29, 2007
Risk assessment to guide the prevention of cervical cancerPhilip E Castle, Mario Sideri, Jose Jeronimo, et al.
Pageof 50

Showing results (71-80 of 498) with videos related to

Sort By:
Pageof 50
American Journal of Clinical Pathology|February 6, 2007
The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assaysMark H Stoler, Philip E Castle, Diane Solomon, et al.
Obstetrics and Gynecology|June 2, 2007
Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significanceMahboobeh Safaeian, Diane Solomon, Sholom Wacholder, et al.
Journal of Lower Genital Tract Disease|April 4, 2020
An Introduction to the 2019 ASCCP Risk-Based Management Consensus GuidelinesMark Schiffman, Nicolas Wentzensen, Rebecca B Perkins, et al.
Preventive Medicine|May 19, 2024
Response letter to "Understanding the age-related epithelial shifts at the uterine cervix and the area of risk for squamous cell cervical cancer"Kanan T Desai, John Doorbar, Silvia de Sanjose, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 15, 2005
Evaluating the risk of cervical precancer with a combination of cytologic, virologic, and visual methodsSophia S Wang, Joan L Walker, Mark Schiffman, et al.
JAMA|August 8, 2023
Cervical Cancer Screening: A ReviewRebecca B Perkins, Nicolas Wentzensen, Richard S Guido, et al.
American Journal of Clinical Pathology|April 19, 2007
The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS reportPhilip E Castle, Mark H Stoler, Diane Solomon, et al.
Global Health, Science and Practice|July 1, 2018
Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening?Shannon L Silkensen, Mark Schiffman, Vikrant Sahasrabuddhe, et al.
Cancer|May 13, 2005
Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytologyMichelle J Khan, Edward E Partridge, Sophia S Wang, et al.
Journal of Lower Genital Tract Disease|December 29, 2007
Risk assessment to guide the prevention of cervical cancerPhilip E Castle, Mario Sideri, Jose Jeronimo, et al.
Pageof 50